Clemons TE, Gillies MC, Chew EY, Bird AC, Peto T, Wang JJ, Mitchell P, Ramdas WD, Vingerling JR, Macular Telangiectasia... View Article
Balaskas K, Leung I, Sallo FB, Clemons TE, Bird AC, Peto T. Retina. 2014 Aug;34(8):1630-6.
Oh JH, Oh J, Togloom A, Kim SW, Huh K. Retina. 2014 Jun;34(6):1123-31.
Karth PA, Raja SC, Brown DM, Kim JE. Retina. 2014 May;34(5):907-15.
Heeren TF, Holz FG, Charbel Issa P. Retina. 2014 May;34(5):916-9.
Dr. Rubin has worked in both industry and academia, and has drug discovery experience in both settings. He is currently a Professor at Harvard University, and Director of Translational Medicine at the Harvard Stem Cell Institute. His research interests focus on identifying therapeutics for orphan neural disorders.
Dr. Quaggin is the Charles H. Mayo Professor of Medicine and Chief of Nephology at Northwestern University. Her research program focuses on the genetic pathways required to establish and maintain microvascular beds.
Dr. Isacoff is a Professor at UC Berkeley, in the Department of Neuroscience. He has been a pioneer of optogenetics research, using light to study neural circuits and neural transmission. He applies this research to neuronal diseases, including retinal disease, to restore neural function.
Dr. Holmes was appointed a Howard Hughes Medical Investigator at Duke University School of Medicine in 1974 and later became the James B. Wyngaarden Professor of Medicine. He was recruited to the University of Pennsylvania School of Medicine in 1991 as the Chair of the Department of Medicine and the Frank Wister Thomas Professor of Medicine and Genetics.
On the Diagnosis: How long has it been since you were diagnosed with MacTel? About two years, but about four... View Article
